DNTH — Dianthus Therapeutics, Inc. stock price, charts and financials

QT62Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
108.15
-0.77-0.71%
OverviewShort InterestFilings
DNTHQT62Dianthus Therapeutics, Inc.·NASDAQ
108.15-0.71%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 04, 20268-KCurrent report
Aug 04, 202610-QQuarterly report
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 13, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 11, 20264Statement of changes in beneficial ownership
May 05, 20268-KCurrent report
#1 / 25 of 176
Page
▼
/ 8